Actively Recruiting

Phase 4
Age: 18Years - 100Years
All Genders
NCT06320041

Efficacy and Safety of Oliceridine for Moderate to Severe Acute Pain After Orthopedic Surgery

Led by The Fourth Affiliated Hospital of Zhejiang University School of Medicine · Updated on 2025-02-17

162

Participants Needed

1

Research Sites

126 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial\] is to further explore the effectiveness and safety of oxelidine in the treatment of moderate to severe acute pain after orthopedic surgery. The main question it aims to answer is: Pain management after orthopaedic surgery provides more effective and safe drug options, provides new options for clinical treatment, and provides a scientific basis for clinical practice. Participants will be asked to pain score in the different time, treatments they'll be given and use optimal drug. Researchers will compare analgesic effect of oxelidine of different dose.

CONDITIONS

Official Title

Efficacy and Safety of Oliceridine for Moderate to Severe Acute Pain After Orthopedic Surgery

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Elective orthopedic surgery under general anesthesia
  • Ability to communicate normally and express pain accurately
Not Eligible

You will not qualify if you...

  • Advanced tumor
  • Other acute or chronic pain conditions
  • Severe obesity (BMI 30 kg/m2 or higher)
  • Pregnant or lactating women
  • Allergy to opioids
  • Sleep apnea syndrome
  • Long-term opioid treatment
  • Mental or nervous system diseases
  • Gastrointestinal obstruction
  • Chronic obstructive pulmonary disease or pulmonary heart disease
  • Cardiovascular disease
  • Abnormal liver function during screening
  • Abnormal renal function during screening

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

Yiwu, Zhejiang, China, 322000

Actively Recruiting

Loading map...

Research Team

D

Dongmei Ma

CONTACT

L

Li Li

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here